A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears in Select Devices

April 23, 2024 updated by: Ethicon Endo-Surgery

A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears and Generator G11 in Pediatric Surgical Procedures (General) and Adult Surgical Procedures (General, Gynecological, Urological, and Thoracic)

This prospective, single-arm, multi-center study will collect clinical data in a post-market setting for the pediatric population (general surgical procedures) and adult population (general, gynecological, urological, and thoracic surgical procedures). Investigators will perform each procedure using the device in compliance with their standard surgical approach and the HARMONIC 1100 Shears and Generator G11 instructions for use.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

165

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montreal, Canada
        • Recruiting
        • Centre Hospitalier de l'Universite de Montreal
      • Toronto, Canada
        • Recruiting
        • Toronto General Hospital
        • Contact:
          • Yasufuku
    • Scotland
      • Edinburgh, Scotland, United Kingdom
        • Recruiting
        • Western General Hospital
        • Contact:
          • Leung
    • Florida
      • Jacksonville, Florida, United States, 32207
        • Recruiting
        • Baptist Health
        • Contact:
          • Morgenthal
    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Recruiting
        • Indiana University
        • Contact:
          • Sundaram
      • Indianapolis, Indiana, United States, 46202
        • Completed
        • IU Health University Hospital
      • Indianapolis, Indiana, United States, 46202
        • Completed
        • Riley Hospital for Children at Indiana University Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Pediatric population:

  1. Primary laparoscopic non-emergent procedure (general) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  2. Less than 18 years of age at the time of procedure; and
  3. The subject's parent/legal guardian must be willing to give permission for the subject to participate in the study and provide written informed consent for the subject. In addition, assent must be obtained from pediatric subjects who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric subject is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study), the parent/legal guardian's written informed consent for the subject will be acceptable for the subject to be included in the study.

Adult population:

  1. Primary laparoscopic elective procedure (general, gynecological, urological, or thoracic) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  2. Willingness to give consent and comply with all study-related evaluations and visit schedule; and
  3. At least 18 years of age.

Exclusion Criteria:

Preoperative

  1. Physical or psychological condition which would impair study participation;
  2. Female subjects, of childbearing age, who are pregnant; or
  3. Enrollment in a concurrent interventional clinical study that could impact the study endpoints.

Intraoperative

1. The HARMONIC 1100 Shears were not attempted to be used for at least one single vessel transection during the surgical procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pediatric; adult (HPB, lower gastrointestinal, gastric, gynecological, urological, thoracic)
Any pediatric or adult (hepato-pancreato-biliary, lower gastrointestinal, gastric, gynecological, urological, thoracic) procedures where the HARMONIC 1100 Shears is used for vessel transection according to instructions for use.
HARMONIC 1100 Shears is used for vessel transection according to instructions for use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of vessel transections with an achievement of Grade 3 or lower for each vessel transection based on the scale described below
Time Frame: Intraoperative
  • Grade 1: no bleeding at transection site;
  • Grade 2: minor bleeding at transection site, no intervention needed;
  • Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, basic energy devices (monopolar and/or bipolar) and/or touchups with HARMONIC 1100 Shears; or
  • Grade 4: significant bleeding (e.g., pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or ligation with use of additional hemostatic measures (e.g., hemoclips, staples, sutures, fibrin sealants, other advanced energy products).
Intraoperative
Number of Participants with Device-related Adverse Events (AEs)
Time Frame: 2 to 6 weeks postoperative
Number of participants with device-related (possible, probable, or causal) AEs will be reported. An AE is defined as any untoward medical occurrence, regardless of its relationship to the study device or the study procedure. An untoward medical occurrence includes any new, undesirable medical experience or worsening of a pre-existing condition, which occurs throughout the duration of the clinical study.
2 to 6 weeks postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of 5-point scale scores for sealing and transection of lymphatic vessels completed by HARMONIC 1100 Shears
Time Frame: Intraoperative
A 5-point scale (very dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, or very satisfied) will be used to describe how satisfied the surgeon was with the sealing and transection of lymphatic vessels by HARMONIC 1100 Shears.
Intraoperative
The distribution of grades (1-4) seen from the use of the hemostasis grading scale (primary outcome measure) for each vessel transected will be calculated
Time Frame: Intraoperative
Intraoperative
The number of any additional hemostasis measures required to achieve hemostasis for any Grade 4 vessel transections will be collected
Time Frame: Intraoperative
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ethicon Endo-Surgery Clinical Trial, Ethicon Endo-Surgery
  • Principal Investigator: Troy Markel, MD, Riley Hospital for Children at Indiana University Health
  • Principal Investigator: Attila Nakeeb, MD, IU Health University Hospital
  • Principal Investigator: Moishe Liberman, MD, Centre Hospitalier de l'Universite de Montreal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2021

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

April 30, 2024

Study Registration Dates

First Submitted

August 5, 2021

First Submitted That Met QC Criteria

August 31, 2021

First Posted (Actual)

September 9, 2021

Study Record Updates

Last Update Posted (Actual)

April 24, 2024

Last Update Submitted That Met QC Criteria

April 23, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ENG_2020_06

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Procedures

Clinical Trials on HARMONIC 1100 Shears

3
Subscribe